Oral baclofen reduces visceral pain-related pseudo-affective responses to colorectal distension in rats: Relation between plasma exposure and efficacy

References

• Bowery NG. GABAB receptor: a site of therapeutic benefit. Curr Opin Pharmacol 2006;6:37–43.
   PubMed Web of Science ®Google Scholar
• Hwang JH, Yaksh TL. The effect of spinal GABA receptor agonists on tactile allodynia in surgically-induced neuropathic pain model in the rat. Pain 1997;70:15–22.
   PubMedGoogle Scholar
• Canavero S, Bonicalzi V. Drug therapy of trigeminal neuralgia. Expert Rev Neurother 2006;6:429–40.
   PubMedGoogle Scholar
• Enna SJ, McCarson KE. The role of GABA in the mediation and perception of pain. Adv Pharmacol 2006;54:1–27.
   PubMedGoogle Scholar
• Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 2004;28:140–75.
   PubMed Web of Science ®Google Scholar
• Dones I. Intrathecal baclofen for the treatment of spasticity. Acta Neurochir Suppl 2007;97:185–8.
   PubMedGoogle Scholar
• Heetla HW, Staal MJ, Kliphuis C, van Laar T. The incidence and management of tolerance in intrathecal baclofen therapy. Spinal Cord 2009;47:751–6.
   PubMed Web of Science ®Google Scholar
• Brusberg M, Ravnefjord A, Martinsson R, Larsson H, Martinez V, Lindström E. The GABAB agonist baclofen, and the positive allosteric modulator CGP7930, inhibit visceral pain-related responses to colorectal distension in rats. Neuropharmacology 2009;56:362–7.
   PubMedGoogle Scholar
• Urwyler S, Mosbacher J, Lingenhoehl K, Heid J, Hofstetter K, Froestl W, Positive allosteric modulation of native and recombinant γ-aminobutyric acidB receptors by 2,6-tert-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol Pharmacol 2001;60:963–71.
   PubMedGoogle Scholar
• Page AJ, Blackshaw LA. GABA(B) receptors inhibit mechanosensitivity of primary afferent endings. J Neurosci 1999;19:8597–602.
   PubMedGoogle Scholar
• Smid SD, Young RL, Cooper NJ, Blackshaw LA. GABABR expressed on vagal afferent neurons inhibit gastric mechanosensitivity in ferret proximal stomach. Am J Physiol 2001;281:G1494–501.
   PubMed Web of Science ®Google Scholar
• Arvidsson S, Phillis B, Brusberg M, Kristensson E, Martinez V, Larsson H, The GABA-B receptor agonist baclofen inhibits mechano-sensitive colon afferents in vitro in mice and the visceromotor response to colorectal distension in awake rats. Gastroenterology 2005;128(Suppl 2):A-222–3.
   Google Scholar
• Sengupta JN, Medda BK, Shaker R. Effect of GABAB receptor agonist on distension-sensitive pelvic afferent fibers innervating rat colon. Am J Physiol 2002;283:G1343–51.
   PubMed Web of Science ®Google Scholar
• Hara K, Saito Y, Kirihara Y, Sakura S. The interaction between gamma-aminobutyric acid agonists and diltiazem in visceral antinociception in rats. Anesth Analg 2004;98:1380–4.
   PubMedGoogle Scholar
• Hara K, Saito Y, Kirihara Y, Yamada Y, Sakura S, Kosaka Y. The interaction of antinociceptive effects of morphine and GABA receptor agonists within the rat spinal cord. Anesth Analg 1999;89:422–7.
   PubMedGoogle Scholar
• Rey E, Alvarez Sanchez A, Diaz-Rubio M. Which is the best distension protocol to study rectal sensitivity in the irritable bowel syndrome? Rev Esp Enferm Dig 2002;94:211–20.
   PubMedGoogle Scholar
• Ng C, Malcolm A, Hansen R, Kellow JE. Distension technique influences the relationship between colonic and rectal hypersensitivity in irritable bowel syndrome. Neurogastroenterol Motil 2006;18:206–10.
   PubMedGoogle Scholar
• Tammpere A, Brusberg M, Axenborg J, Hirsch I, Larsson H, Lindström E. Evaluation of manometric recordings as pseudo-affective responses to noxious colorectal distension in rat. Pain 2005;116:220–6.
   PubMed Web of Science ®Google Scholar
• Käll E, Lindström E, Martinez V. The serotonin reuptake inhibitor citalopram does not affect colonic sensitivity or compliance in rats. Eur J Pharmacol 2007;570:203–11.
   PubMedGoogle Scholar
• Brusberg M, Arvidsson S, Kang D, Larsson H, Lindström E, Martinez V. CB1 receptors mediate the analgesic effects of cannabinoids on colorectal distension-induced visceral pain in rodents. J Neurosci 2009;29:1554–64.
   PubMed Web of Science ®Google Scholar
• Lindström E, Brusberg M, Hughes PA, Martin CM, Brierley SM, Phillis BD, Involvement of metabotropic glutamate 5 receptor in visceral pain. Pain 2008;137:295–305.
   PubMedGoogle Scholar
• Ravnefjord A, Brusberg M, Kang D, Bauer U, Larsson H, Lindström E, Martinez V. Involvement of the transient receptor potential vanilloid 1 (TRPV1) in the development of acute visceral hyperalgesia during colorectal distension in rats. Eur J Pharmacol 2009;611:85–91.
   PubMedGoogle Scholar
• Bartholini G. GABA receptor agonists: pharmacological spectrum and therapeutic actions. Med Res Rev 1985;5:55–75.
   PubMedGoogle Scholar
• Al-Dahan MI, Jalilian Tehrani MH, Thalmann RH. Regulation of gamma-aminobutyric acidB (GABAB) receptors in cerebral cortex during the estrous cycle. Brain Res 1994;640:33–9.
   PubMedGoogle Scholar
• Arvidsson S, Larsson M, Larsson H, Lindström E, Martinez V. Assessment of visceral pain-related pseudo-affective responses to colorectal distension in mice by intracolonic manometric recordings. J Pain 2006;7:108–18.
   PubMed Web of Science ®Google Scholar
• Faigle JW, Keberle H. The chemistry and kinetics of Lioresal. Postgrad Med J 1972;48(Suppl 5):9–13.
   PubMedGoogle Scholar
• Potes CS, Neto FL, Castro-Lopes JM. Inhibition of pain behaviour by GABAB receptors in the thalamic ventrobasal complex: effect on normal rats subjected to the formalin test of nociception. Brain Res 2006;1115:37–47.
   PubMedGoogle Scholar
• Potes CS, Neto FL, Castro-Lopes JM. Administration of baclofen, a γ-aminobutyric acid type B agonist in the thalamic ventrobasal complex, attenuates allodynia in monoarthritic rats subjected to the ankle-bend test. J Neurosci Res 2006;83:515–23.
   PubMedGoogle Scholar
• Lindström E, Ravnefjord A, Brusberg M, Hjorth S, Larsson H, Martinez V. The selective 5-hydroxytryptamine 1A antagonist, AZD7371 [3(R)-(N,N-dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide (R,R)-tartrate monohydrate] (robalzotan tartrate monohydrate), inhibits visceral pain-related visceromotor, but not autonomic cardiovascular, responses to colorectal distension in rats. J Pharmacol Exp Ther 2009;329:1048–55.
   PubMed Web of Science ®Google Scholar
• Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome. Am J Gastroenterol 2008;103:2562–9.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lehmann A, Rigda R, Dent J, Holloway RH. Control of transient lower oesophageal spinchter relaxations and reflux by the GABAB agonist baclofen in patients with gastro-oesophageal refluxdisease. Gut 2002;50:19–24.
   PubMed Web of Science ®Google Scholar
• Aisen ML, Dietz MA, Rossi P, Cederbaum JM, Kutt H. Clinical and pharmacokinetic aspects of high dose oral baclofen therapy. J Am Paraplegia Soc 1992;15:211–16.
   PubMedGoogle Scholar
• Lehmann A, Antonsson M, Holmberg AA, Blackshaw LA, Brändén L, Bräuner-Osborne H, (R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action. J Pharmacol Exp Ther 2009;331:504–12.
   PubMed Web of Science ®Google Scholar
• Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007;19(Suppl 1):62–88.
   PubMedGoogle Scholar
• Ravnefjord A, Brusberg M, Larsson H, Lindström E, Martínez V. Effects of pregabalin on visceral pain responses and colonic compliance in rats. Br J Pharmacol 2008;155:407–16.
   PubMed Web of Science ®Google Scholar